FEASIBILITY OF USING A FACTORY-CALIBRATED CGM SYSTEM TO DIAGNOSE TYPE 2 DIABETES

被引：0
|
作者：
Frank, S. [1 ]
Hames, K. [2 ]
Jbaily, A. [1 ]
Welsh, J. [2 ]
Stroyeck, C. [1 ]
Price, D. [1 ]
机构：
[1] Dexcom Inc, Data Sci, San Diego, CA USA
[2] Dexcom Inc, Clin Affairs, San Diego, CA USA
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2021年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
O075 / #50
引用
收藏
页码：A48 / A48
页数：1
相关论文
共 50 条
  • [41] GlucoMen Day CGM System Accuracy Assessment in Individuals with Type 1 Diabetes
    Simic, Amra
    Taucher, Marlene T.
    Hochfellner, Daniel A.
    Poettler, Tina
    Aberer, Felix
    Mader, Julia K.
    DIABETES, 2021, 70
  • [42] Glucomen Day® CGM system accuracy assessment in individuals with type 1 diabetes
    Simic, Amra
    Taucher, Marlene
    Hochfellner, Daniel
    Poettler, Tina
    Aberer, Felix
    Mader, Julia
    WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (SUPPL 6) : 200 - 200
  • [43] Perceived Barriers to Physical Activity in People with Type 1 Diabetes Using CGM
    Andre, Camille C.
    Kudva, Yogish C.
    Dadlani, Vikash
    Cescon, Marzia
    Mccrady-Spitzer, Shelly K.
    Church, Mei Mei
    Reid, Corey
    Kumari, Kanchan
    Choudhary, Divya
    Doyle, Francis J., III
    Dassau, Eyal
    Pinsker, Jordan E.
    DIABETES, 2019, 68
  • [44] Investigation of Usefulness of Continuous Glucose Monitoring System (CGM) in Outpatient Care of Japanese Patients with Type 2 Diabetes
    Sato, Junko
    Kanazawa, Akio
    Ikeda, Fuki
    Shigihara, Nayumi
    Kawaguchi, Minako
    Komiya, Koji
    Uchida, Toyoyoshi
    Ogihara, Takeshi
    Shimizu, Tomoaki
    Fujitani, Yoshio
    Watada, Hirotaka
    DIABETES, 2014, 63 : A215 - A215
  • [45] USE OF CGM WITH PEOPLE WITH DIABETES TYPE 2 TREATED WITH BASAL INSULIN ONLY
    Leelarathna, L.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A2 - A2
  • [46] Estimating Optimal CGM Wear Time for Individuals with Type 2 Diabetes Not on Insulin
    Barua, Souptik
    Upadhyay, Dhairya A.
    Curran, Margaret
    Berube, Lauren
    Popp, Collin
    Pompeii, Mary Lou
    Wang, Josephine C.
    Vanegas, Sally M.
    Dorcely, Brenda
    Hu, Lu
    St-Jules, David
    Bergman, Michael
    Segal, Eran
    Sevick, Mary Ann
    DIABETES, 2024, 73
  • [47] Correlates of CGM Uptake among Adults with Type 2 Diabetes in Primary Care
    Mayberry, Lindsay S.
    Roddy, Mckenzie K.
    Jaser, Sarah S.
    Elasy, Tom A.
    DIABETES, 2022, 71
  • [48] ACCURACY ASSESSMENT OF THE NEW GLUCOMEN® DAY CGM SYSTEM IN INDIVIDUALS WITH TYPE 1 DIABETES
    Simic, A.
    Taucher, M.
    Hochfellner, D.
    Dietrich, M.
    Poerttler, T.
    Aberer, F.
    Mader, J.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A117 - A117
  • [49] ACUTE HEALTHCARE UTILIZATION PATTERNS AMONG PEOPLE WITH TYPE 2 DIABETES USING PROFESSIONAL CGM IN THE UNITED STATES
    Sierra, J. A.
    Shah, M.
    Vigersky, R.
    Kaufman, F. R.
    Flores, Z.
    Gill, M. S.
    Stoltenberg, L. S.
    VALUE IN HEALTH, 2018, 21 : S172 - S172
  • [50] Monitoring Stage 2 to Stage 3 Transition in Type 1 Diabetes Using Continuous Glucose Monitoring (CGM)
    Frohnert, Brigitte I.
    Sepulveda, Flor
    Stoughton, Jessica E.
    Steck, Andrea
    Simmons, Kimber M.
    DIABETES, 2023, 72
12345